Am. J. Respir. Crit. Care Med., Volume 161, Number 3, March 2000, 866-871

Predictors of Improvements in Daytime Function Outcomes with CPAP Therapy

RUTH N. KINGSHOTT, MARJORIE VENNELLE, CAROL J. HOY, HEATHER M. ENGLEMAN, IAN J. DEARY, and NEIL J. DOUGLAS

Respiratory Medicine Unit and Department of Psychology, University of Edinburgh, Edinburgh, United Kingdom

Continuous positive airway pressure (CPAP) therapy improves daytime function in the sleep apnea/ hypopnea syndrome (SAHS) but it is unclear which patients benefit and what factors predict this improvement. To test the hypothesis that brief arousals from sleep predict improvements in daytime functioning with CPAP therapy, we prospectively studied 62 patients with polysomnography-defined SAHS. Each underwent daytime function assessments at baseline and after 6 mo of CPAP therapy to measure objective sleepiness, psychological well-being, quality of life, and cognitive performance. The microarousal frequency and AHI were poor predictors of improvements in daytime function with CPAP. Measures of hypoxemia predicted improvements in the mean sleep latency on the maintenance of wakefulness test, SAHS symptoms, quality of life, and reaction time, but such correlations were weak or moderate only explaining between 7% and 22% of variance. Significant relationships were found between CPAP use and improvements in self-ratings of daytime function. Results suggest that standard polysomnographic baseline variables are poor predictors of the response to CPAP therapy. Kingshott RN, Vennelle M, Hoy CJ, Engleman HM, Deary IJ, Douglas NJ. Predictors of improvements in daytime function outcomes with CPAP therapy.

This article has been cited by other articles:

				J. A. Dempsey, S. C. Veasey, B. J. Morgan, and C. P. O'Donnell Pathophysiology of Sleep Apnea Physiol Rev, January 1, 2010; 90(1): 47 - 112. [Abstract] [Full Text] [PDF]

				B. Buyse and the participants of working group 2 Treatment effects of sleep apnoea: where are we now? Eur. Respir. Rev., December 1, 2007; 16(106): 146 - 168. [Abstract] [Full Text] [PDF]

				Y. Zhu, P. Fenik, G. Zhan, E. Mazza, M. Kelz, G. Aston-Jones, and S. C. Veasey Selective Loss of Catecholaminergic Wake Active Neurons in a Murine Sleep Apnea Model J. Neurosci., September 12, 2007; 27(37): 10060 - 10071. [Abstract] [Full Text] [PDF]

				Y. Nussbaumer, K. E. Bloch, T. Genser, and R. Thurnheer Equivalence of Autoadjusted and Constant Continuous Positive Airway Pressure in Home Treatment of Sleep Apnea Chest, March 1, 2006; 129(3): 638 - 643. [Abstract] [Full Text] [PDF]

				K. Hashimoto, T. Ono, E.-i. Honda, K. Maeda, H. Shinagawa, S. Tsuiki, S. Hiyama, T. Kurabayashi, and K. Ohyama Effects of mandibular advancement on brain activation during inspiratory loading in healthy subjects: a functional magnetic resonance imaging study J Appl Physiol, February 1, 2006; 100(2): 579 - 586. [Abstract] [Full Text] [PDF]

				O. Senn, T. Brack, E. W. Russi, and K. E. Bloch A Continuous Positive Airway Pressure Trial as a Novel Approach to the Diagnosis of the Obstructive Sleep Apnea Syndrome Chest, January 1, 2006; 129(1): 67 - 75. [Abstract] [Full Text] [PDF]

				R. J. Thomas, B. R. Rosen, C. E. Stern, J. W. Weiss, and K. K. Kwong Functional imaging of working memory in obstructive sleep-disordered breathing J Appl Physiol, June 1, 2005; 98(6): 2226 - 2234. [Abstract] [Full Text] [PDF]

				G V Robinson, J R Stradling, and R J O Davies Sleep {middle dot} 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension Thorax, December 1, 2004; 59(12): 1089 - 1094. [Abstract] [Full Text] [PDF]

				P. Lloberes, S. Marti, G. Sampol, A. Roca, T. Sagales, X. Munoz, and M. Ferrer Predictive Factors of Quality-of-Life Improvement and Continuous Positive Airway Pressure Use in Patients With Sleep Apnea-Hypopnea Syndrome: Study at 1 Year Chest, October 1, 2004; 126(4): 1241 - 1247. [Abstract] [Full Text] [PDF]

				C F P George Sleep {middle dot} 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome Thorax, September 1, 2004; 59(9): 804 - 807. [Abstract] [Full Text] [PDF]

				J. R. L. Schwartz, M. Hirshkowitz, M. K. Erman, and W. Schmidt-Nowara Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea: A 12-Week, Open-Label Study Chest, December 1, 2003; 124(6): 2192 - 2199. [Abstract] [Full Text] [PDF]

				S. T. Kuna A 54-Year-Old Man With Obstructive Sleep Apnea JAMA, October 23, 2002; 288(16): 2032 - 2039. [Full Text] [PDF]

				A. Valipour, A.D. McGown, H. Makker, C. O'Sullivan, and S.G. Spiro Some factors affecting cerebral tissue saturation during obstructive sleep apnoea Eur. Respir. J., August 1, 2002; 20(2): 444 - 450. [Abstract] [Full Text] [PDF]

				M. BARNES, D. HOUSTON, C. J. WORSNOP, A. M. NEILL, I. J. MYKYTYN, A. KAY, J. TRINDER, N. A. SAUNDERS, R. D. MCEVOY, and R. J. PIERCE A Randomized Controlled Trial of Continuous Positive Airway Pressure in Mild Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 773 - 780. [Abstract] [Full Text] [PDF]

				T.A. McFadyen, C.A. Espie, N. McArdle, N.J. Douglas, and H.M. Engleman Controlled, prospective trial of psychosocial function before and after continuous positive airway pressure therapy Eur. Respir. J., December 1, 2001; 18(6): 996 - 1002. [Abstract] [Full Text] [PDF]

				A. I. PACK, J. E. BLACK, J. R. L. SCHWARTZ, and J. K. MATHESON Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1675 - 1681. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Sleep-disordered Breathing, Control of Breathing, Respiratory Muscles, Pulmonary Function Testing, Nitric Oxide, and Bronchoscopy in AJRCCM 2000 Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1362 - 1375. [Full Text] [PDF]